Overview
Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract Symptoms
Status:
Completed
Completed
Trial end date:
2011-12-14
2011-12-14
Target enrollment:
0
0
Participant gender:
Male
Male
Summary
Clinical study to examine the safety, tolerability and efficacy of long-term combination therapy of tamsulosin and solifenacin in the treatment of males with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) with a substantial storage component.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Astellas Pharma Europe B.V.Treatments:
Solifenacin Succinate
Tamsulosin
Criteria
Inclusion Criteria:- Completion of 12 weeks double-blind treatment in Study 905-CL-055
Exclusion Criteria:
- Any significant PVR volume (>150 mL)